Tiffany Harris‐Brown
- Molecular Medicine top 10%
- Infectious Diseases
- Applied Microbiology and Biotechnology top 5%
- Epidemiology
- Pharmacology
- Co-authors
- David L. PatersonThomas V. RileyLuis Furuya‐KanamoriCharlotte HuberArchie C. A. ClementsPatrick N. A. HarrisEugene AthanSanjoy K. Paul
- Topics
- Antibiotic Use and Resistance (6 papers)Clostridium difficile and Clostridium perfringens research (5 papers)Microscopic Colitis (4 papers)
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- New England Journal of MedicineJournal of Clinical MicrobiologyJournal of Medical Internet Research
- Partner nations
- AustraliaSingaporeUnited Kingdom
In The Last Decade
Tiffany Harris‐Brown
12 papers receiving 179 citations
Peers
Comparison fields: 5 of 54
- Molecular Medicine 62
- Infectious Diseases 57
- Applied Microbiology and Biotechnology 53
- Epidemiology 50
- Pharmacology 36
Countries citing papers authored by Tiffany Harris‐Brown
This map shows the geographic impact of Tiffany Harris‐Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany Harris‐Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany Harris‐Brown more than expected).
Fields of papers citing papers by Tiffany Harris‐Brown
This network shows the impact of papers produced by Tiffany Harris‐Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany Harris‐Brown. The network helps show where Tiffany Harris‐Brown may publish in the future.
Co-authorship network of co-authors of Tiffany Harris‐Brown
This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany Harris‐Brown. A scholar is included among the top collaborators of Tiffany Harris‐Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany Harris‐Brown. Tiffany Harris‐Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 30 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2) | 2 |
| 9 | 26 | |
| 10 | 22 | |
| 11 | 6 | |
| 12 | 31 | |
| 13 | 54 | |
| 14 | 1 | |
| 15 | 2 |
About Tiffany Harris‐Brown
Tiffany Harris‐Brown is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 15 papers that have together received 183 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Microscopic Colitis (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Molecular Medicine (62 citations) and Critical Care and Intensive Care Medicine (21 citations). Tiffany Harris‐Brown has collaborated with scholars based in Australia, Singapore and United Kingdom. Frequent co-authors include David L. Paterson, Thomas V. Riley, Luis Furuya‐Kanamori, Charlotte Huber, Archie C. A. Clements, Patrick N. A. Harris, Eugene Athan, Sanjoy K. Paul, Benjamin A. Rogers and Paul R. Ingram. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Microbiology and Journal of Medical Internet Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.